Psychopharmacologic Therapies for Irritable Bowel Syndrome

Volume: 50, Issue: 3, Pages: 655 - 669
Published: Sep 1, 2021
Abstract
Psychopharmacologic therapies are beneficial in reducing symptoms when treating irritable bowel syndrome (IBS) and other disorders of gut-brain interaction (DGBI). Noradrenaline, serotonin, and dopamine are neurotransmitters of key importance in psychopharmacology and pain-reduction mechanisms. The first-line (tricyclic antidepressants, serotonin noradrenaline reuptake inhibitors, selective serotonin reuptake inhibitors) and second-line...
Paper Details
Title
Psychopharmacologic Therapies for Irritable Bowel Syndrome
Published Date
Sep 1, 2021
Volume
50
Issue
3
Pages
655 - 669
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.